Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/20/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Sibylle Neuhoff

Wrong Dr. Sibylle Neuhoff?

Principal Scientist

Phone: +44 *** *** ****  HQ Phone
Email: s***@***.com
Simcyp Limited
Blades Enterprise Centre John Street
Sheffield, South Yorkshire S2 4SU
United Kingdom

Company Description: As a Certara portfolio company, Simcyp will continue to provide platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human...   more
14 Total References
Web References
Dr Sibylle Neuhoff ...
www.simcyp.com, 20 Sept 2013 [cached]
Dr Sibylle Neuhoff (Principal Scientist, Simcyp) will presenting a talk at the 3rd World Conference on Physico Chemical Methods in Drug Discovery and Development. he conference takes place 22nd - 26th September 2013 in Dubrovnik, Croatia. Dr Neuhoff's talk is entitled 'In vitro - in vivo extrapolation of transporters', and will take place on Wednesday 25th September at 09:00.
Simcyp will be exhibiting at the event and Dr Neuhoff will also be hosting a one-day workshop on Sunday 22nd September. Further details can be found here.
Dr Sibylle Neuhoff ...
www.simcyp.com, 19 Oct 2011 [cached]
Dr Sibylle Neuhoff (Principal Scientist, Simcyp Limited) will be presenting at the upcoming 13th Annual Congress for Clinical Pharmacology. The meeting will be held between the 20th - 22nd October in Zurich, Switzerland. The event provides a forum for attendees to discuss current issues including the efficacy and safety of medicines, the challenge for the clinical pharmacologist in patient care, pharmacoepidemiology, the role of electronic systems in the assessment of drug risks, the importance of safety networks and new targeted therapies.
Dr Neuhoff will be providing an oral presentation entitled 'Prediction of transporter-mediated drug-drug interactions: consequences from the White Paper' in Symposium VII on the 21st October. In addition, Dr Neuhoff will provide a poster presentation (poster number 92) entitled 'P-gp efflux has no impact on dose proportionality of digoxin bioavailability over a dose range of 0.125 to 1.5mg: The outcome of a new PBPK model, that includes the in vitro transporter information, is consistent with the clinical observations'.
Dr Sibylle Neuhoff ...
www.simcyp.com, 11 Mar 2011 [cached]
Dr Sibylle Neuhoff (Principal Scientist, Simcyp Limited), Dr Karen Rowland-Yeo (Senior Scientific Advisor and Head of Bioinformatics, Simcyp Limited) and Mr Matthew Harwood (Research Scientist, Simcyp Limited) will be attending and presenting at the AAPS workshop held this month.
PCMDDD conference
www.iapchem.org, 26 Oct 2012 [cached]
Sibylle Neuhoff, Simcyp Ltd, UK
ABC of Modelling Transporter Data - ...
www.iapchem.org, 26 Oct 2012 [cached]
ABC of Modelling Transporter Data - Principles and Practical Know How, Sibylle Neuhoff, Simcyp Ltd, UK
...
Sibylle Neuhoff, Simcyp (a Certara company), UK, In vitro - in vivo extrapolation of transporters
Other People with the name "Neuhoff":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304